
    
      This is an observational, multicenter, drug registry Study. The study will have a total
      duration of 15 years, including a 10-year inclusion period. No diagnostic, therapeutic or
      experimental intervention is involved. Subjects will receive clinical assessments,
      medications and treatments solely as determined by their study physician.
    
  